n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Cirrhosis in 3 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuhisa, S | 1 |
| Otani, H | 1 |
| Okazaki, T | 1 |
| Yamashita, K | 1 |
| Akita, Y | 1 |
| Sato, D | 1 |
| Moriguchi, A | 1 |
| Iwasaka, T | 1 |
| Zhang, P | 1 |
| Xu, X | 1 |
| Hu, X | 1 |
| van Deel, ED | 1 |
| Zhu, G | 1 |
| Chen, Y | 1 |
| Zhou, M | 1 |
| Chen, JY | 1 |
| Chao, ML | 1 |
| Zhang, C | 1 |
| Shi, ZG | 1 |
| Zhou, XC | 1 |
| Xie, LP | 1 |
| Sun, SX | 1 |
| Huang, ZR | 1 |
| Luo, SS | 1 |
| Ji, Y | 1 |
3 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Cirrhosis
| Article | Year |
|---|---|
N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.
Topics: Acetylcysteine; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Benzylamines; Cardiomyop | 2008 |
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
Topics: Amidines; Animals; Aortic Diseases; Atrial Natriuretic Factor; Benzylamines; Cardiomegaly; Chronic D | 2007 |
S-nitrosylation of c-Jun N-terminal kinase mediates pressure overload-induced cardiac dysfunction and fibrosis.
Topics: Angiotensin II; Animals; Aorta; Fibroblasts; Fibrosis; Heart Diseases; Humans; Imines; JNK Mitogen-A | 2022 |